Bioequivalence Study of Vigabatrin ORPHELIA Pharma 500mg Soluble Tablets and SabrilTM 500mg Granules for Oral Administration

Clinical trial NCT04468282 · COMPLETED

Trial details

NCT number: NCT04468282
Sponsor: Orphelia Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Therapeutic Equivalency

Start date: 2017-04-04
Primary completion: 2017-08-08
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.